ABSTRACT
INTRODUCTION
Osteoarthritis (OA, degenerative joint disease, osteoarthrosis) is the most common form of arthritis in dogs and cats. It is a chronic, progressive and irreversible joint disease, which ultimately results in degeneration of hyaline articular cartilage in association with alterations in the subchondral bone metabolism, periarticular osteophytosis, and a variable degree of synovial inflammation [6, 19, 30] .
The treatment of osteoarthritis is most often conservative and multimodal. A majority of cases are managed with nonsteroidal antiinflammatory drugs or other analgesics combined with weight reduction, nutritional and exercise management. Osteoarthritis in dogs is associated with a variety of clinical signs such as stiffness, lameness, and gait alterations [10] . Exercise intolerance, muscle atrophy, joint swelling, capsular and extracapsular fibrosis, joint effusion, reduced range of motion, crepitus, and pain on joint manipulation are also present in many cases.
In recent years, OA therapy has been the subject of many studies in regenerative medicine. The use of MSCs for tis- Generally, secreted membrane vesicles could be broadly divided into two classes: 1) vesicles formed by inward budding of endolysosomal vesicles and released through exocytosis; and 2) vesicles which are shed from the plasma membrane [16] .
ROLE OF MESENCHYMAL STEM CELLS-DERIVED EXOSOMES
Exosomes and microvesicles are the two most representative vesicle types; exosomes, 40~100 nm in diameter and microvesicles 100 nm~1000 nm in diameter. They contain numerous proteins, lipids as well as messengers and micro
RNAs responsible for intercellular communication. Cells often exchange substances and information through the release of these particles [21] . [33] indicate that the secretion of exosomes is a general cellular function. 
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